Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Assets | ||||
| Current Assets | ||||
| Other current assets | 0 | 1,770 | 1,860 | 870 |
| TOTAL | $N/A | $1,770 | $1,860 | $870 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 540 | 540 | 640 | 1,060 |
| TOTAL | $540 | $540 | $640 | $1,060 |
| Total Assets | $540 | $2,310 | $2,500 | $1,930 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,060 | 1,510 | 1,300 | 430 |
| Accrued Expenses | 1,430 | 1,080 | 1,180 | 870 |
| Other current liabilities | 3,060 | 1,910 | 1,620 | 1,800 |
| TOTAL | $7,460 | $6,750 | $5,860 | $4,190 |
| Non-Current Liabilities | ||||
| TOTAL | $4,170 | $4,150 | $4,070 | $2,250 |
| Total Liabilities | $11,630 | $10,900 | $9,930 | $6,440 |
| Shareholders' Equity | ||||
| Common Shares | 10 | 10 | 10 | 3 |
| Other shareholders' equity | -3,020 | -3,350 | -3,780 | -4,260 |
| TOTAL | $108,470 | $108,080 | $107,740 | $47,163 |
| Total Liabilities And Equity | $120,100 | $118,980 | $117,670 | $53,603 |